Available to SourceHuman Prescription DrugOncology & Specialty

Xadago (Safinamide Mesylate)

100 mg/1 · Film-Coated Tablet

By MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.

Safinamide Mesylate · Tablet · 100 mg

NDC: 27505-111
Route: Oral
Therapeutic class: Breast Cancer Resistance Protein Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor , Monoamine Oxidase-B Inhibitors [MoA]
Marketing category: NDA

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Oncology & Specialty

See all →

Xadago (Safinamide Mesylate)

Additional information

Request this medication.

Related in Oncology & Specialty

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)